论文部分内容阅读
盐酸万乃洛韦（Valaciclovirhydrochloride）是由Wellcom，研制的抗病毒新药，四川抗菌素工业研究所及其制药厂在国内首光研制，商品名为明竹欣。1997年10月～1998年6月，我科对明竹欣治疗带状癌疹进行疗效观察，并与阿昔洛韦进行比较，现报告如下。1病例选择按现行诊断标准[1]
Valaciclovir hydrochloride is a new antiviral drug developed by Wellcom. Its antibacterial industry research institute and its pharmaceutical factory are the first in China to develop their brand name Mingzhuxin. 1997 October ~ 1998 June, our department of Ming Zhu Xin treatment of band-like cancer efficacy observed, and compared with acyclovir, are as follows. 1 case selection according to the current diagnostic criteria [1]